6.48
price up icon0.00%   0.00
after-market Handel nachbörslich: 6.49 0.010 +0.15%
loading

Finanzdaten der Kezar Life Sciences Inc-Aktie (KZR)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- 7.00 - -
Operating Expenses
31.45%
23.71
34.59 32.53 26.78 24.52
Interest Income/Expense
0.25%
0.40
0.399 0.396 0.385 0.37
Operating Income/Loss
31.45%
-23.71
-34.59 -25.53 -26.78 -24.52
Income/Loss From Continuing Operations Before Tax
32.86%
-21.66
-32.26 7.00 -24.31 -22.20
Income Tax Expense/Benefit
-
- - - -
Income/Loss From Continuing Operations After Tax
32.86%
-21.66
-32.26 -23.10 -24.31 -22.20
Net Income/Loss
32.86%
-21.66
-32.26 -23.10 -24.31 -22.20
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
117.75K%
72.80
0.0618 72.68 72.46 72.33
Diluted Average Shares
117.75K%
72.80
0.0618 72.68 72.46 72.33
Basic Earnings Per Share
31.82%
-0.30
-0.44 -0.32 -0.34 -0.31
Diluted Earnings Per Share
31.82%
-0.30
-0.44 -0.32 -0.34 -0.31
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$39.42
price down icon 3.95%
$351.17
price down icon 0.32%
$21.50
price down icon 3.85%
$5.30
price down icon 2.03%
biotechnology ONC
$224.99
price down icon 0.84%
$123.77
price up icon 2.39%
Kapitalisierung:     |  Volumen (24h):